Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lisata Therapeutics Inc LSTA

Healthcare Biotechnology
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to... see more

Recent & Breaking News (NDAQ:LSTA)

Caladrius Biosciences Announces $25.0 Million Private Placement

GlobeNewswire January 21, 2021

Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction

GlobeNewswire January 19, 2021

Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021

GlobeNewswire January 6, 2021

Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

GlobeNewswire December 21, 2020

Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

GlobeNewswire December 14, 2020

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update

GlobeNewswire December 14, 2020

Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum

GlobeNewswire December 10, 2020

Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference

GlobeNewswire December 9, 2020

Caladrius Biosciences to Present at American Heart Association's Virtual Scientific Sessions 2020

GlobeNewswire November 10, 2020

Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results

GlobeNewswire November 5, 2020

Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November

GlobeNewswire November 4, 2020

Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors

GlobeNewswire November 2, 2020

Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time

GlobeNewswire October 29, 2020

Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°

GlobeNewswire October 21, 2020

Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage

GlobeNewswire October 8, 2020

Caladrius Biosciences to Present at the Alliance for Regenerative Medicine's Virtual Cell and Gene Meeting on the Mesa

GlobeNewswire October 7, 2020

Caladrius Biosciences to Present at the BIO Investor Forum Digital

GlobeNewswire October 6, 2020

Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

GlobeNewswire September 14, 2020

Caladrius Biosciences to Participate in Landmark's 10th Annual Investing for Cures Virtual Forum

GlobeNewswire September 10, 2020

Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan

GlobeNewswire September 9, 2020